Back to the main directory
Press Release
- EquifaxMD Canada et FrontLobby réalisent leur première étude sur les données de location by GlobeNewsWire
- Rights and Issues Investment Trust PLC: Net Asset Value(s) by EQS Group AG
- Earnix and Guidewire Partner to Provide Robust Integration of Mission-Critical Solutions to Insurers by BusinessWire
- Arkema : Déclaration des transactions sur actions propres réalisées du 05 septembre 2022 et le 09 septembre by BusinessWire
- Endexx Corp.’s New Subsidiary, HYLA, Targets Eight New Countries for Launch of Its Non-Nicotine, Guarana-Based Vape Product in 2022, Including Germany, Italy, and Israel by GlobeNewsWire
- Brown & Brown, Inc. announces the asset acquisition of Smithwick & Mariners Insurance, MidCoast Insurance and Chapman & Chapman Insurance by GlobeNewsWire
- Radisson recoupe 17,11 g/t Au sur 2,00 m, 12,66 g/t Au sur 1,80 m et 8,69 g/t Au sur 2,20 m confirmant le potentiel d’expansion des ressources le long des vecteurs #3 et #4 au projet O’Brien by GlobeNewsWire
- Recherche : TotalEnergies et l’Université Technique du Danemark créent un centre d’excellence dans les énergies décarbonées by BusinessWire
- MAG Silver Provides Juanicipio Commissioning Update by GlobeNewsWire
- Amundi Asset Management: Final Terms by EQS Group AG
- Amundi Asset Management: Final Terms by EQS Group AG
- Amryt Announces New Patent for Mycapssa® by GlobeNewsWire
- DSM: Net Asset Value(s) by GlobeNewsWire
- Microbot Medical to Review Recent Progress During H.C. Wainwright’s 24th Annual Global Investment Conference by GlobeNewsWire
- Rubius Therapeutics Announces Strategic Update by GlobeNewsWire
- Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss by GlobeNewsWire
- Medicenna Announces Clinical Collaboration with Merck to evaluate MDNA11 in combination with KEYTRUDA® (pembrolizumab) in ABILITY Trial by GlobeNewsWire
- Xos Unveils Advanced Driver Assistance System (ADAS) Features by GlobeNewsWire
- Atea to Advance Global Phase 3 Registrational Study of Bemnifosbuvir in High-Risk Non-Hospitalized Patients with COVID-19 by GlobeNewsWire
- Securitize Launches Fund Providing Tokenized Exposure to KKR Fund for the First Time in the U.S by BusinessWire
- Convatec Group PLC: Scrip Dividend – Calculation Price by EQS Group AG
- Eastman Provides Update on Third-Quarter 2022 Financial Results by BusinessWire
- BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts by GlobeNewsWire
- The Shyft Group Secures Initial Pre-Order for Blue Arc™ All-Electric Delivery Walk-In Vans by GlobeNewsWire
- Parker Completes Acquisition of Meggitt PLC by GlobeNewsWire